UniProt ID | NR4A2_HUMAN | |
---|---|---|
UniProt AC | P43354 | |
Protein Name | Nuclear receptor subfamily 4 group A member 2 | |
Gene Name | NR4A2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 598 | |
Subcellular Localization |
Cytoplasm. Nucleus. Mostly nuclear oxidative stress promotes cytoplasmic localization. |
|
Protein Description | Transcriptional regulator which is important for the differentiation and maintenance of meso-diencephalic dopaminergic (mdDA) neurons during development. It is crucial for expression of a set of genes such as SLC6A3, SLC18A2, TH and DRD2 which are essential for development of mdDA neurons (By similarity).. | |
Protein Sequence | MPCVQAQYGSSPQGASPASQSYSYHSSGEYSSDFLTPEFVKFSMDLTNTEITATTSLPSFSTFMDNYSTGYDVKPPCLYQMPLSGQQSSIKVEDIQMHNYQQHSHLPPQSEEMMPHSGSVYYKPSSPPTPTTPGFQVQHSPMWDDPGSLHNFHQNYVATTHMIEQRKTPVSRLSLFSFKQSPPGTPVSSCQMRFDGPLHVPMNPEPAGSHHVVDGQTFAVPNPIRKPASMGFPGLQIGHASQLLDTQVPSPPSRGSPSNEGLCAVCGDNAACQHYGVRTCEGCKGFFKRTVQKNAKYVCLANKNCPVDKRRRNRCQYCRFQKCLAVGMVKEVVRTDSLKGRRGRLPSKPKSPQEPSPPSPPVSLISALVRAHVDSNPAMTSLDYSRFQANPDYQMSGDDTQHIQQFYDLLTGSMEIIRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRSNPVEGKLIFCNGVVLHRLQCVRGFGEWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTERHGLKEPKRVEELQNKIVNCLKDHVTFNNGGLNRPNYLSKLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPAIIDKLFLDTLPF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
71 | Phosphorylation | MDNYSTGYDVKPPCL HCCCCCCCCCCCCEE | 20.04 | - | |
91 | Sumoylation | SGQQSSIKVEDIQMH CCCCCEEEEEEEECC | 41.33 | - | |
125 | Phosphorylation | GSVYYKPSSPPTPTT CCEEECCCCCCCCCC | 51.85 | 17890097 | |
126 | Phosphorylation | SVYYKPSSPPTPTTP CEEECCCCCCCCCCC | 43.35 | 17681692 | |
129 | Phosphorylation | YKPSSPPTPTTPGFQ ECCCCCCCCCCCCCE | 36.33 | 17681692 | |
132 | Phosphorylation | SSPPTPTTPGFQVQH CCCCCCCCCCCEEEC | 23.71 | 17681692 | |
174 | Phosphorylation | KTPVSRLSLFSFKQS CCCCCEEEEEEECCC | 26.68 | 22210691 | |
177 | Phosphorylation | VSRLSLFSFKQSPPG CCEEEEEEECCCCCC | 36.51 | 29214152 | |
181 | Phosphorylation | SLFSFKQSPPGTPVS EEEEECCCCCCCCCC | 33.38 | 29255136 | |
185 | Phosphorylation | FKQSPPGTPVSSCQM ECCCCCCCCCCCCEE | 26.70 | 17681692 | |
226 | Ubiquitination | AVPNPIRKPASMGFP ECCCCCCCCHHCCCC | 45.73 | - | |
246 | Phosphorylation | HASQLLDTQVPSPPS CHHHHHCCCCCCCCC | 31.28 | 25002506 | |
250 | Phosphorylation | LLDTQVPSPPSRGSP HHCCCCCCCCCCCCC | 51.06 | 25850435 | |
253 | Phosphorylation | TQVPSPPSRGSPSNE CCCCCCCCCCCCCCC | 53.29 | 25002506 | |
256 | Phosphorylation | PSPPSRGSPSNEGLC CCCCCCCCCCCCCCE | 24.84 | 25850435 | |
258 | Phosphorylation | PPSRGSPSNEGLCAV CCCCCCCCCCCCEEC | 49.57 | 25850435 | |
275 | Phosphorylation | DNAACQHYGVRTCEG CCCHHHHHCCCCCCC | 7.46 | - | |
279 | Phosphorylation | CQHYGVRTCEGCKGF HHHHCCCCCCCCCCH | 16.71 | - | |
296 | Ubiquitination | RTVQKNAKYVCLANK HHHHHCCCEEEECCC | 47.84 | - | |
303 | Ubiquitination | KYVCLANKNCPVDKR CEEEECCCCCCCCHH | 55.08 | - | |
335 | Phosphorylation | MVKEVVRTDSLKGRR CEEEEEECCCCCCCC | 20.52 | 28102081 | |
337 | Phosphorylation | KEVVRTDSLKGRRGR EEEEECCCCCCCCCC | 31.22 | 28355574 | |
347 | Phosphorylation | GRRGRLPSKPKSPQE CCCCCCCCCCCCCCC | 67.21 | 16223362 | |
351 | Phosphorylation | RLPSKPKSPQEPSPP CCCCCCCCCCCCCCC | 40.10 | 23403867 | |
356 | Phosphorylation | PKSPQEPSPPSPPVS CCCCCCCCCCCCCHH | 49.00 | 25850435 | |
359 | Phosphorylation | PQEPSPPSPPVSLIS CCCCCCCCCCHHHHH | 45.26 | 29255136 | |
363 | Phosphorylation | SPPSPPVSLISALVR CCCCCCHHHHHHHHH | 26.26 | 23403867 | |
366 | Phosphorylation | SPPVSLISALVRAHV CCCHHHHHHHHHHHC | 22.35 | 23403867 | |
375 | Phosphorylation | LVRAHVDSNPAMTSL HHHHHCCCCCCCCCC | 43.56 | 23663014 | |
380 | Phosphorylation | VDSNPAMTSLDYSRF CCCCCCCCCCCHHHH | 28.39 | 23663014 | |
381 | Phosphorylation | DSNPAMTSLDYSRFQ CCCCCCCCCCHHHHH | 13.22 | 23663014 | |
384 | Phosphorylation | PAMTSLDYSRFQANP CCCCCCCHHHHHCCC | 13.67 | 23663014 | |
385 | Phosphorylation | AMTSLDYSRFQANPD CCCCCCHHHHHCCCC | 26.70 | 23663014 | |
530 | Ubiquitination | RVEELQNKIVNCLKD HHHHHHHHHHHHHHH | 34.76 | - | |
558 | Sumoylation | YLSKLLGKLPELRTL HHHHHHCCCHHHHHH | 61.92 | - | |
558 | Ubiquitination | YLSKLLGKLPELRTL HHHHHHCCCHHHHHH | 61.92 | - | |
558 | Sumoylation | YLSKLLGKLPELRTL HHHHHHCCCHHHHHH | 61.92 | - | |
577 | Sumoylation | LQRIFYLKLEDLVPP HHHHHEEEHHHCCCC | 38.15 | 14559918 | |
577 | Sumoylation | LQRIFYLKLEDLVPP HHHHHEEEHHHCCCC | 38.15 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
126 | S | Phosphorylation | Kinase | MK01 | P28482 | PhosphoELM |
126 | S | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
129 | T | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
132 | T | Phosphorylation | Kinase | MK01 | P28482 | PhosphoELM |
132 | T | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
185 | T | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NR4A2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NR4A2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SFPQ_HUMAN | SFPQ | physical | 19144721 | |
NCOR2_HUMAN | NCOR2 | physical | 19144721 | |
SIN3A_HUMAN | SIN3A | physical | 19144721 | |
SMCA4_HUMAN | SMARCA4 | physical | 17043312 | |
SMCA2_HUMAN | SMARCA2 | physical | 17043312 | |
RUNX1_HUMAN | RUNX1 | physical | 21468021 | |
RXRA_HUMAN | RXRA | physical | 15604093 | |
CSN5_HUMAN | COPS5 | physical | 15604093 | |
RXRB_HUMAN | RXRB | physical | 15604093 | |
TCAL5_HUMAN | TCEAL5 | physical | 20195357 | |
BAZ1B_HUMAN | BAZ1B | physical | 20195357 | |
RXRA_HUMAN | RXRA | physical | 7705655 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND MASSSPECTROMETRY. |